SINGAPORE — Singapore and Vietnam have been profitable in controlling the coronavirus in 2020 and are prone to maintain the scenario contained subsequent yr, an economist mentioned this week.
"Those two countries probably stand out most positively," mentioned Joseph Incalcaterra of HSBC Global Research when responding to a query on which Southeast Asian countries will have the ability to maintain Covid below management and easily roll out vaccines.
Singapore "brought their previous outbreaks under control and, … at a time when most countries in the world are actually tightening restrictions, Singapore's going the opposite way," the chief ASEAN economist informed CNBC's "Squawk Box Asia" on Tuesday.
The city-state this week entered the third section of its reopening, and now permits gatherings of eight individuals, up from 5. Tourist sights can enhance their working capacities from 50% to 65% as soon as they obtain approval from the authorities.
People swim at a seaside at East Coast Park on December 25, 2020 in Singapore.Suhaimi Abdullah | Getty Images News | Getty Images
Incalcaterra mentioned Singapore additionally has an efficient vaccine technique.
"Thanks to a relatively small population, the outlook for Singapore is extremely bright for 2021 by relative standards," he mentioned.
Prime Minister Lee Hsien Loong mentioned there will be sufficient vaccines for "everyone in Singapore" by the third quarter of 2021. The nation was the primary in Asia to obtain a cargo of Pfizer-BioNTech vaccines on Dec. 21, 2020.
HSBC's Incalcaterra additionally praised Vietnam's dealing with of the virus, and mentioned its response to the pandemic allowed the nation to keep up its fame as a "very good destination" for international direct funding. The nation has been seen as a substitute manufacturing hub for corporations that wish to transfer out of China.
"We saw that actually FDI this year remains very resilient into Vietnam," he mentioned.
Overall, nevertheless, Southeast Asia might not benefit from a vaccine in the close to future, given the logistical difficulties in rural elements of the area. "It's very unlikely that we see a significant share of the population inoculated in 2021," he mentioned.
Separately, Incalcaterra mentioned Southeast Asia has been "hit very hard" this yr. "From a domestic perspective, the traditional consumer engine of these economies is no longer intact."
"We really don't have great visibility on the short-term recovery, given how deep the damage is," he added.
While digital exports had been "relatively bright," HSBC is specializing in how rapidly consumption and funding can rebound in the area.
He mentioned countries had been pursuing "very ambitious infrastructure programs" to make the area a "reliable manufacturing production base." These tasks had been stalled due to the coronavirus.
"Until the virus is under control … we're not going to see this investment engine regain its momentum," he mentioned. "That's, I think, the biggest short-term hindrance to growth in Southeast Asia."
primarily based on web site supplies www.cnbc.com